Long-term outcomes of keratolimbal allograft for total limbal stem cell deficiency using combined immunosuppressive agents and correction of ocular surface deficits

Archives of Ophthalmology

Volumn 127, Issue 11, 2009, Pages 1428-1434

  Liang, Lingyi ^a,b   Sheha, Hosam ^b,c   Tseng, Scheffer C G ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b OCULAR SURFACE CENTER   (United States)

^c RESEARCH INSTITUTE OF OPHTHALMOLOGY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIGLAUCOMA AGENT; DEXAMETHASONE; MITOMYCIN C; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OFLOXACIN; PREDNISOLONE ACETATE; PREDNISONE; STEROID; TACROLIMUS; TRIAMCINOLONE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ADULT; AGED; ALLOGRAFT; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVITIS; CONTROLLED STUDY; CORNEA DISEASE; CORNEA LIMBUS; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DRY EYE; EYELID RECONSTRUCTION; EYELID REFLEX; FEMALE; FOLLOW UP; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAOCULAR HYPERTENSION; KERATOLIMBAL ALLOGRAFT; LAGOPHTHALMOS; LIMBAL STEM CELL DEFICIENCY; MALE; OUTCOME ASSESSMENT; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE; SYMBLEPHARON; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT; VISUAL ACUITY; ALLOTRANSPLANTATION; AMNION; CYTOLOGY; DRUG COMBINATION; EPITHELIUM CELL; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RISK FACTOR; STEM CELL; STEM CELL TRANSPLANTATION; SUTURING METHOD; TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; AGED; AMNION; COMBINED MODALITY THERAPY; CORNEAL DISEASES; DRUG THERAPY, COMBINATION; EPITHELIAL CELLS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIMBUS CORNEAE; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; RISK FACTORS; STEM CELL TRANSPLANTATION; STEM CELLS; SUTURE TECHNIQUES; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 70449720867     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.263     Document Type: Article

References (37)

1. Schermer A, Galvin S, Sun T-T. Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J Cell Biol. 1986;103(1):49-62. (Pubitemid 16066991)
2. Cotsarelis G, Cheng SZ, Dong G, Sun T-T, Lavker RM. Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell. 1989;57(2):201-209. (Pubitemid 19112360)
3. Lavker RM, Tseng SC, Sun TT. Corneal epithelial stem cells at the limbus: looking at some old problems from a new angle. Exp Eye Res. 2004;78(3):433-446.
4. Puangsricharern V, Tseng SCG. Cytologic evidence of corneal diseases with limbal stem cell deficiency. Ophthalmology. 1995;102(10):1476-1485.
5. Dua HS, Saini JS, Azuara-Blanco A, Gupta P. Limbal stem cell deficiency: concept, aetiology, clinical presentation, diagnosis and management. Indian J Ophthalmol. 2000;48(2):83-92.
6. Espana EM, Di Pascuale M, Grueterich M, Solomon A, Tseng SC. Keratolimbal allograft in corneal reconstruction. Eye. 2004;18(4):406-417.
7. Holland EJ, Schwartz GS. Epithelial stem-cell transplantation for severe ocular surface disease. N Engl J Med. 1999;340(22):1752-1753.
8. Daya SM, Ilari L. Living related conjunctival limbal allograft for the treatment of stem cell deficiency. Ophthalmology. 2001;108(1):126-133.
9. Tsai RJF, Tseng SCG. Human allograft limbal transplantation for corneal surface reconstruction. Cornea. 1994;13(5):389-400.
10. Tsubota K, Toda I, Saito H, Shinozaki N, Shimazaki J. Reconstruction of the corneal epithelium by limbal allograft transplantation for severe ocular surface disorders. Ophthalmology. 1995;102(10):1486-1496.
11. Holland EJ, Djalilian AR, Schwartz GS. Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique. Ophthalmology. 2003;110(1):125-130.
12. Tan DTH, Ficker LA, Buckley RJ. Limbal transplantation. Ophthalmology. 1996;103(1):29-36.
13. Holland EJ. Epithelial transplantation for the management of severe ocular surface disease. Trans Am Ophthalmol Soc. 1996;94:677-743.
14. Hill JC. Systemic cyclosporine in high-risk keratoplasty: short- versus long-term therapy. Ophthalmology. 1994;101(1):128-133. (Pubitemid 24044153)
15. Tsubota K, Satake Y, Kaido M, et al. Treatment of severe ocular surface disorders with corneal epithelial stem-cell transplantation. N Engl J Med. 1999;340(22):1697-1703. (Pubitemid 29252597)
16. Ilari L, Daya SM. Long-term outcomes of keratolimbal allograft for the treatment of severe ocular surface disorders. Ophthalmology. 2002;109(7):1278-1284. (Pubitemid 34700918)
17. Solomon A, Ellies P, Anderson DF, et al. Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology. 2002;109(6):1159-1166.
18. Boratyńska M, Banasik M, Patrzalek D, Klinger M. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection. Ann Transplant. 2006;11(2):51-56.
19. Tabbara KF. Pharmacologic strategies in the prevention and treatment of corneal transplant rejection. Int Ophthalmol. 2008;28(3):223-232.
20. Maruyama-Hosoi F, Shimazaki J, Shimmura S, Tsubota K. Changes observed in keratolimbal allograft. Cornea. 2006;25(4):377-382.
21. Holland EJ, Schwartz GS. The evolution of epithelial transplantation for severe ocular surface disease and a proposed classification system. Cornea. 1996;15(6):549-556.
22. Samson CM, Nduaguba C, Baltatzis S, Foster CS. Limbal stem cell transplantation in chronic inflammatory eye disease. Ophthalmology. 2002;109(5):862-868. (Pubitemid 34465217)
23. Shimazaki J, Shimmura S, Fujishima H, Tsubota K. Association of preoperative tear function with surgical outcome in severe Stevens-Johnson syndrome. Ophthalmology. 2000;107(8):1518-1523. (Pubitemid 30825863)
24. Prabhasawat P, Tseng SCG. Impression cytology study of epithelial phenotype of ocular surface reconstructed by preserved human amniotic membrane. Arch Ophthalmol. 1997;115(11):1360-1367. (Pubitemid 28055862)
25. Tseng SCG, Prabhasawat P, Barton K, Gray T, Meller D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol. 1998;116(4):431-441. (Pubitemid 28169742)
26. Cher I. Blink-related microtrauma: when the ocular surface harms itself. Clin Experiment Ophthalmol. 2003;31(3):183-190. (Pubitemid 36833366)
27. Pflugfelder SC, Tseng SCG, Sanabria O, et al. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea. 1998;17(1):38-56. (Pubitemid 28047008)
28. Kheirkhah A, Blanco G, Casas V, Hayashida Y, Raju VK, Tseng SC. Surgical strategies for fornix reconstruction based on symblepharon severity. Am J Ophthalmol. 2008;146(2):266-275.
29. Dohlman CH, Terada H. Keratoprosthesis in pemphigoid and Stevens-Johnson syndrome. Adv Exp Med Biol. 1998;438:1021-1025.
30. Tseng SC, Tsubota K. Important concepts for treating ocular surface and tear disorders. Am J Ophthalmol. 1997;124(6):825-835. (Pubitemid 27523160)
31. Ayyala RS. Penetrating keratoplasty and glaucoma. Surv Ophthalmol. 2000;45(2):91-105.
32. Schwartz GS, Gomez JAP, Holland EJ. Pre-operative staging of disease severity. In: Holland EJ, Mannis MJ, eds. Ocular Surface Disease Medical and Surgical Management. New York, NY: Springer; 2002:158-167.
33. Jorge S, Guerra J, Santana A, Mil-Homens C, Prata MM. Mycophenolate mofetil: ten years' experience of a renal transplant unit. Transplant Proc. 2008;40(3):700-704. (Pubitemid 351608632)
34. Brum S, Nolasco F, Sousa J, et al. Leukopenia in kidney transplant patients with the association of valganciclovir and mycophenolate mofetil. Transplant Proc. 2008;40(3):752-754. (Pubitemid 351608651)
35. Müller H, Solari S, Zuniga C, et al. Immunosuppression with generic tacrolimus and mycophenolate mofetil in renal transplant recipients: preliminary report in Chile. Transplant Proc. 2008;40(3):705-707.
36. Alloway R, Mogilishetty G, Cole L, et al. Ocular surface transplant recipients experience minimal immunosuppression complications: implications for composite tissue transplants [abstract]. Am J Transplant. 2007;1058:419.
37. Sloper CM, Powell RJ, Dua HS. Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts. Ophthalmology. 2001;108(10):1838-1844.